# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193805-24-001257
Filing Date
2024-10-22
Accepted
2024-10-22 06:45:28
Documents
32
Period of Report
2024-10-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | e663960_8k-immunic.htm iXBRL | 8-K | 21462
2 |  | e663960_ex99-1.htm | EX-99.1 | 19952
3 |  | e663960_ex99-2.htm | EX-99.2 | 11867
7 | GRAPHIC | image1.jpg | GRAPHIC | 4723
8 | GRAPHIC | slide1.jpg | GRAPHIC | 174052
9 | GRAPHIC | slide2.jpg | GRAPHIC | 352504
10 | GRAPHIC | slide3.jpg | GRAPHIC | 114526
11 | GRAPHIC | slide4.jpg | GRAPHIC | 186743
12 | GRAPHIC | slide5.jpg | GRAPHIC | 60699
13 | GRAPHIC | slide6.jpg | GRAPHIC | 199036
14 | GRAPHIC | slide7.jpg | GRAPHIC | 142930
15 | GRAPHIC | slide8.jpg | GRAPHIC | 202873
16 | GRAPHIC | slide9.jpg | GRAPHIC | 166859
17 | GRAPHIC | slide10.jpg | GRAPHIC | 145038
18 | GRAPHIC | slide11.jpg | GRAPHIC | 44378
19 | GRAPHIC | slide12.jpg | GRAPHIC | 42827
20 | GRAPHIC | slide13.jpg | GRAPHIC | 152997
21 | GRAPHIC | slide14.jpg | GRAPHIC | 161641
22 | GRAPHIC | slide15.jpg | GRAPHIC | 169466
23 | GRAPHIC | slide16.jpg | GRAPHIC | 123237
| Complete submission text file | 0001193805-24-001257.txt |  | 3604256

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL SCHEMA FILE | imux-20241022.xsd | EX-101.SCH | 3003
5 | XBRL LABEL FILE | imux-20241022_lab.xml | EX-101.LAB | 34240
6 | XBRL PRESENTATION FILE | imux-20241022_pre.xml | EX-101.PRE | 22351
34 | EXTRACTED XBRL INSTANCE DOCUMENT | e663960_8k-immunic_htm.xml | XML | 3779

Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 241384641
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)